glp-1 receptor agonists weight loss Balancing and muscle in GLP1 agonist therapy Changes in weight with glucagon-like

The incidence rate ratio (IRR) of subsequent cancer in patients with T2DM was 1.73, which was higher than that of individuals without DM, and it increased in both men and women

This history proves you are not looking for an easy way out

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Patients using GLP-1 therapy often experience significant reductions in hemoglobin A1c levels and improved beta-cell function crucial for insulin production and overall pancreatic health

[DOI] [PubMed] [Google Scholar] 75.Incretin hormones in obesity and related cardiometabolic disorders: the clinical perspective

Gastrointestinal Side Effects Although studies on GLP-1 RAs clearly demonstrate substantial clinical benefits, their short- and long-term safety profiles have not yet been fully elucidated